GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (BOM:500257) » Definitions » Gross Margin %

Lupin (BOM:500257) Gross Margin % : 67.85% (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Lupin Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Lupin's Gross Profit for the three months ended in Mar. 2024 was ₹33,213 Mil. Lupin's Revenue for the three months ended in Mar. 2024 was ₹48,951 Mil. Therefore, Lupin's Gross Margin % for the quarter that ended in Mar. 2024 was 67.85%.


The historical rank and industry rank for Lupin's Gross Margin % or its related term are showing as below:

BOM:500257' s Gross Margin % Range Over the Past 10 Years
Min: 56.23   Med: 62.7   Max: 67.03
Current: 66.2


During the past 13 years, the highest Gross Margin % of Lupin was 67.03%. The lowest was 56.23%. And the median was 62.70%.

BOM:500257's Gross Margin % is ranked better than
80.77% of 988 companies
in the Drug Manufacturers industry
Industry Median: 46.48 vs BOM:500257: 66.20

Lupin had a gross margin of 67.85% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Lupin was 0.30% per year.


Lupin Gross Margin % Historical Data

The historical data trend for Lupin's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Gross Margin % Chart

Lupin Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.56 60.36 56.23 58.33 66.20

Lupin Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.59 65.40 65.53 66.02 67.85

Competitive Comparison of Lupin's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Lupin's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lupin's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lupin's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Lupin's Gross Margin % falls into.



Lupin Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Lupin's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=130128.7 / 196563.4
=(Revenue - Cost of Goods Sold) / Revenue
=(196563.4 - 66434.7) / 196563.4
=66.20 %

Lupin's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=33212.7 / 48951.1
=(Revenue - Cost of Goods Sold) / Revenue
=(48951.1 - 15738.4) / 48951.1
=67.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Lupin  (BOM:500257) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lupin had a gross margin of 67.85% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Lupin Gross Margin % Related Terms

Thank you for viewing the detailed overview of Lupin's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lupin (BOM:500257) Business Description

Traded in Other Exchanges
Address
Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400 055
Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The operations of the company are limited to one segment, namely pharmaceuticals and related products. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Lupin (BOM:500257) Headlines

No Headlines